US FDA Wants Advice About Advisory Committees: Try Having Some?

 
• By Michael McCaughan
conference room
The focus on adcomm perception does not make much sense given that CDER is having so few meetings, McCaughan argues. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers